Axogen, Inc. — Director's Dealing 2020

Jun 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-06-01

Reporting Person: Levine Alan M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-03	Stock Option (right to purchase)	$15.44	A	10710	Acquired	2029-09-03	Common Stock (10710)	Direct
2019-09-03	Restricted Stock Units	$	A	2591	Acquired		Common Stock (2591)	Direct

Footnotes

F1: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on September 3, 2019, one year from the anniversary of the grant date. Two-thirds of the annual equity grant value is in the form of non-qualified stock options and one-third of the annual equity grant value is in the form of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.